1-5 of 5
Michael D. De Lay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Fludarabine Treatment of TCL-1 Transgenic Mice Promotes Drug Resistance through a Mechanism Not Involving p53 Mutations: Implications for Patients with Chronic Lymphocytic Leukemia (CLL).

Michael D. De Lay, Amy J. Johnson, PhD, David M. Lucas, PhD, Darius T. Durr, Ellen M. Sass, Virginia M. Goettl, DVM, PhD, Amy Lehman, David Jarjoura, PhD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2007) 110 (11): 3095.
https://doi.org/10.1182/blood.V110.11.3095.3095
Published: 2007
Journal Articles

The Plant-Derived Agent Silvestrol Has B-Cell Selective Activity In Vitro in Chronic Lymphocytic Leukemia Patient Cells and In Vivo in the Tcl-1 Mouse Model of CLL.

David M. Lucas, PhD, Ryan B. Edwards, Michael D. De Lay, Derek A. West, Gerard Lozanski, MD, Amy J. Johnson, PhD, Angela A. Salim, PhD, Thomas S. Lin, MD, PhD, John C. Byrd, MD, A. Douglas Kinghorn, PhD, Michael R. Grever, MD
Journal: Blood
Blood (2007) 110 (11): 3123.
https://doi.org/10.1182/blood.V110.11.3123.3123
Published: 2007
Journal Articles

The Novel Histone Deacetylase Inhibitor OSU-HDAC42 Has Class I and II Histone Deacetylase (HDAC) Inhibitory Activity and Represents a Novel Therapy for Chronic Lymphocytic Leukemia.

Derek A. West, BS, David M. Lucas, PhD, Melanie E. Davis, PhD, Michael D. De Lay, BA, Amy J. Johnson, PhD, Sara E. Guster, MS/MBA, Michael A. Freitas, PhD, Mark R. Parthun, PhD, Dasheng Wang, PhD, Samuel K. Kulp, PhD/DVM, Michael R. Grever, MD, Ching-Shih Chen, PhD, John C. Byrd, MD
Journal: Blood
Blood (2006) 108 (11): 2807.
https://doi.org/10.1182/blood.V108.11.2807.2807
Published: 2006
Journal Articles

The Geldanamycin Derivative DMAG Demonstrates Improved Cytotoxicity and Down-Modulation of Hsp90 Client Proteins Relative to 17-AAG in Chronic Lymphocytic Leukemia (CLL) Cells: Justification for Clinical Trials in CLL.

Amy J. Johnson, PhD, Amy J. Wagner, BA, Lisa L. Smith, MS, David M. Lucas, PhD, Michael D. De Lay, BA, Jamie M. Allison, BA, S. Percy Ivy, MD, Thomas S. Lin, MD,PhD, John C. Byrd, MD
Journal: Blood
Blood (2006) 108 (11): 2101.
https://doi.org/10.1182/blood.V108.11.2101.2101
Published: 2006
Journal Articles

Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia

Amy J. Johnson, David M. Lucas, Natarajan Muthusamy, Lisa L. Smith, Ryan B. Edwards, Michael D. De Lay, Carlo M. Croce, Michael R. Grever, John C. Byrd
Journal: Blood
Blood (2006) 108 (4): 1334–1338.
https://doi.org/10.1182/blood-2005-12-011213
Published: 2006